Want to see JP:2934 full AI Analyst Report?
J Frontier Co., Ltd. (2934) AI Stock Analysis
J Frontier Co., Ltd.
(TSE/TYO:2934)
The overall score of 45 reflects significant structural risks overshadowing top-line growth. The primary negative factors dragging down the score are a severely leveraged balance sheet and ongoing net losses, resulting in a highly unfavorable valuation profile. While the stock retains long-term technical support and recently achieved positive free cash flow, the substantial debt burden and unprofitability present material headwinds.
J Frontier Co., Ltd. (2934) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 10.53B
- Dividend Yield
- ―
- Average Volume (3M)
- 6,764
- Price to Earnings (P/E)
- -34.3
- Beta (1Y)
- 0.03
- Revenue Growth
- 9.77%
- EPS Growth
- -470.54%
- Country
- Japan
- Employees
- 201
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Distribution
J Frontier Co., Ltd. Business Overview & Revenue Model
Company Description
J Frontier Co.,Ltd. engages in the healthcare sales, medical care sales, and healthcare marketing businesses in Japan. The company operates SOKUYAKU, a platform for online medical treatment, online medication guidance, home delivery of prescription d...
How the Company Makes Money
Detailed, source-backed information on J Frontier Co., Ltd.’s revenue model (e.g., primary revenue streams, segment mix, pricing/fee structure, and material partnerships) was not available in the provided context. null
J Frontier Co., Ltd. Financial Statement Overview
Summary
Driven by robust revenue growth and a positive turnaround in operating cash flows, heavily offset by severe structural risks including persistent net losses and an alarmingly high debt-to-equity ratio.
Income Statement
45NeutralBalance Sheet
25NegativeCash Flow
65Positive| Breakdown | TTM | May 2025 | May 2024 | May 2023 | May 2022 | May 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.08B | 22.24B | 21.50B | 17.71B | 11.88B | 16.84B |
| Gross Profit | 8.77B | 8.36B | 18.17B | 8.33B | 5.40B | 7.12B |
| EBITDA | 1.01B | 963.76M | 914.54M | -1.22B | 760.66M | -1.54B |
| Net Income | 69.27M | -321.31M | 87.57M | -2.09B | 400.52M | -1.90B |
Balance Sheet | ||||||
| Total Assets | 8.83B | 9.59B | 9.17B | 11.41B | 6.10B | 7.25B |
| Cash, Cash Equivalents and Short-Term Investments | 1.89B | 2.16B | 2.17B | 1.81B | 2.96B | 1.65B |
| Total Debt | 4.04B | 5.31B | 4.34B | 5.16B | 544.39M | 2.14B |
| Total Liabilities | 6.83B | 8.05B | 7.16B | 9.53B | 1.94B | 4.54B |
| Stockholders Equity | 1.37B | 1.23B | 1.41B | 1.14B | 4.14B | 2.48B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 395.24M | 447.19M | -1.54B | -377.40M | -1.94B |
| Operating Cash Flow | 0 | 454.32M | 509.01M | -1.44B | -366.94M | -1.83B |
| Investing Cash Flow | 0 | -1.13B | 470.79M | -1.79B | -860.09M | -1.13B |
| Financing Cash Flow | 0 | 693.89M | -623.13M | 3.39B | 2.56B | 1.45B |
J Frontier Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2934, the sentiment is Positive. The current price of 1971.00 is above the 20-day moving average (MA) of 1963.25, below the 50-day MA of 1992.16, and above the 200-day MA of 1653.82, indicating a neutral trend. The MACD of -12.71 indicates Positive momentum. The RSI at 48.61 is Neutral, neither overbought nor oversold. The STOCH value of 58.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2934.
J Frontier Co., Ltd. Peers Comparison
Overall Rating
JP:448372Outperform
JP:921867.8Neutral
JP:448056Neutral
JP:443850Neutral- JP:293445Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4483 | 72Outperform | JPY 231.69B | 34.70 | ― | 0.52% | 18.89% | 11.66% |
| JP:9218 | 68Neutral | JPY 7.99B | 33.77 | ― | 1.33% | 27.65% | -28.38% |
| JP:4480 | 56Neutral | JPY 73.88B | 41.38 | 12.35% | ― | 24.03% | 34.50% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:4438 | 50Neutral | JPY 2.41B | -4.48 | ― | ― | 14.84% | 30.67% |
| JP:2934 | 45Neutral | JPY 10.18B | -34.30 | ― | ― | 9.77% | -470.54% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:2934 | J Frontier Co., Ltd. | 1971.00 | 180.00 | 10.05% | |
| JP:4480 | Medley, Inc. | 2468.00 | 257.00 | 11.62% | |
| JP:4438 | Welby Inc. | 274.00 | -6.00 | -2.14% | |
| JP:4483 | JMDC Inc. | 3855.00 | -633.17 | -14.11% | |
| JP:9218 | Mental Health Technologies Co. Ltd. | 761.00 | -61.49 | -7.48% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 16, 2026